Goldman Sachs
MESO

Goldman Sachs’s Mesoblast MESO Stock Holding History

Goldman Sachs’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$1.61M – 6678
2025
Q3 		$1.61M Buy
+100,000
New +$1.46M ﹤0.01% 4667

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Goldman Sachs's MESO Position: Q1 2026 in Review

Goldman Sachs increased its Mesoblast (MESO) stake by 0.34% in Q1 2026, buying an estimated $22.7K and bringing the position to 397,215 shares worth $6.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3499.

Goldman Sachs first reported a position in MESO in Q2 2016 and has held it in 20 quarters since. The position peaked at $7.14M in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Goldman Sachs held 397,215 shares of Mesoblast worth $6.11M as of Q1 2026.
  • Goldman Sachs bought 1,365 Mesoblast shares in Q1 2026, an estimated $22.7K.
  • Mesoblast made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3499 holding.
  • Goldman Sachs first reported a position in Mesoblast in Q2 2016 and has held it in 20 quarters since.
  • Goldman Sachs's Mesoblast position peaked at $7.14M in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.